Satoshi Hara

3.5k total citations
210 papers, 2.1k citations indexed

About

Satoshi Hara is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Satoshi Hara has authored 210 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 47 papers in Surgery and 47 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Satoshi Hara's work include Lung Cancer Treatments and Mutations (27 papers), IgG4-Related and Inflammatory Diseases (25 papers) and Renal Diseases and Glomerulopathies (22 papers). Satoshi Hara is often cited by papers focused on Lung Cancer Treatments and Mutations (27 papers), IgG4-Related and Inflammatory Diseases (25 papers) and Renal Diseases and Glomerulopathies (22 papers). Satoshi Hara collaborates with scholars based in Japan, United States and China. Satoshi Hara's co-authors include Zafer Şahinoğlu, Yebin Wang, Toshihiro Wada, Huazhen Fang, Mitsuhiro Kawano, Ichiro Mizushima, Michio Nagata, Daichi Fujimoto, Katsuyoshi Mizuno and Kazunori Yamada and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Satoshi Hara

191 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satoshi Hara Japan 24 571 542 472 421 333 210 2.1k
Jian Qi Australia 19 285 0.5× 124 0.2× 585 1.2× 139 0.3× 334 1.0× 51 2.7k
Julia Glade Bender United States 37 1.2k 2.1× 746 1.4× 1.4k 3.0× 276 0.7× 148 0.4× 134 4.4k
Youngil Koh South Korea 21 729 1.3× 546 1.0× 675 1.4× 90 0.2× 41 0.1× 143 1.7k
Rong Hu United States 29 1.2k 2.1× 1.8k 3.3× 2.4k 5.0× 188 0.4× 44 0.1× 105 5.2k
José Pinto Brazil 18 97 0.2× 231 0.4× 235 0.5× 144 0.3× 128 0.4× 116 1.3k
K.C. Balaji United States 27 481 0.8× 727 1.3× 1.1k 2.2× 658 1.6× 55 0.2× 85 2.2k
Roel A. de Weger Netherlands 37 980 1.7× 445 0.8× 1.4k 2.9× 942 2.2× 389 1.2× 158 4.5k
Yimin Huang China 17 54 0.1× 183 0.3× 404 0.9× 188 0.4× 80 0.2× 73 1.3k
Masayoshi Ishida Japan 20 2.4k 4.3× 409 0.8× 689 1.5× 219 0.5× 78 0.2× 54 4.3k

Countries citing papers authored by Satoshi Hara

Since Specialization
Citations

This map shows the geographic impact of Satoshi Hara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Hara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Hara more than expected).

Fields of papers citing papers by Satoshi Hara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Hara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Hara. The network helps show where Satoshi Hara may publish in the future.

Co-authorship network of co-authors of Satoshi Hara

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Hara. A scholar is included among the top collaborators of Satoshi Hara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Hara. Satoshi Hara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hara, Satoshi, et al.. (2025). Identification of maternal allele sequences of IG-DMR that are essential for neonatal viability. PLoS ONE. 20(5). e0324882–e0324882.
2.
Ai, Junting, Satoshi Hara, Anthony Chang, et al.. (2025). Immune cell quantification of in situ inflammation partitions human lupus nephritis into mechanistic subtypes. Journal of Clinical Investigation. 135(21).
3.
Udagawa, Hibiki, Shingo Matsumoto, Hiroki Izumi, et al.. (2024). Efficacy of immunotherapy in first-line treatment for non-small cell lung cancer with HER2 mutation: Results from LC-SCRUM-Asia.. Journal of Clinical Oncology. 42(16_suppl). 8629–8629. 1 indexed citations
4.
5.
Saito, Takafumi, Kent Kanao, Takayuki Takahashi, et al.. (2023). New risk stratification for adjuvant nivolumab for high‐risk muscle‐invasive urothelial carcinoma. SHILAP Revista de lepidopterología. 5(2). 281–288. 1 indexed citations
6.
7.
Hara, Satoshi, Yoshinori Takahashi, Kiyoaki Ito, et al.. (2023). Case report: Rosai-Dorfman disease with rare extranodal lesions in the pelvis, heart, liver and skin. Frontiers in Oncology. 12. 1083500–1083500. 1 indexed citations
8.
Hara, Satoshi, et al.. (2023). Development of Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome with Pembrolizumab for Lung Squamous Cell Carcinoma. Internal Medicine. 63(14). 2089–2096. 1 indexed citations
9.
Karashima, Shigehiro, Kohei Ogura, Kazuhiro Ogai, et al.. (2023). Impact of gut microbiome on serum IgG4 levels in the general population: Shika-machi super preventive health examination results. Frontiers in Cellular and Infection Microbiology. 13. 1272398–1272398. 2 indexed citations
10.
Hara, Satoshi, et al.. (2022). Normotensive Scleroderma Renal Crisis 8 Years After Living Donor Renal Transplantation: A Case Report. Journal of the American Society of Nephrology. 33(11S). 841–841.
11.
Kawahara, Hiroyuki, Ichiro Mizushima, Seung Yong Shin, et al.. (2022). Clues to mortality trends and their related factors in IgG4-related disease: A Japanese single-centre retrospective study. Modern Rheumatology. 33(6). 1154–1161. 2 indexed citations
12.
Hayashi, Hidetoshi, Shunichi Sugawara, Yasushi Fukuda, et al.. (2021). A Randomized Phase II Study Comparing Nivolumab with Carboplatin–Pemetrexed for EGFR -Mutated NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors (WJOG8515L). Clinical Cancer Research. 28(5). 893–902. 49 indexed citations
13.
Kawamoto, Chiaki, Satoshi Hara, Tamae Ohye, et al.. (2021). Tyrosine hydroxylase conditional KO mice reveal peripheral tissue-dependent differences in dopamine biosynthetic pathways. Journal of Biological Chemistry. 296. 100544–100544. 8 indexed citations
14.
Sun, Feifei, et al.. (2021). Phenotypically concordant but epigenetically discordant monozygotic dichorionic diamniotic twins with Beckwith–Wiedemann syndrome. American Journal of Medical Genetics Part A. 185(10). 3062–3067. 5 indexed citations
15.
Onoe, Tamehito, Satoshi Hara, Kazunori Yamada, et al.. (2021). Significance of kidney biopsy in autosomal dominant tubulointerstitial kidney disease-UMOD: is kidney biopsy truly nonspecific?. BMC Nephrology. 22(1). 1–1. 15 indexed citations
16.
Kunimasa, Kei, Toru Oka, Satoshi Hara, et al.. (2020). Osimertinib is associated with reversible and dose-independent cancer therapy-related cardiac dysfunction. Lung Cancer. 153. 186–192. 24 indexed citations
17.
Fujinaga, Shuichiro, Daishi Hirano, Satoshi Hara, et al.. (2008). . Japanese journal of pediatric nephrology. 21(1). 1–5.
18.
Yokote, Taiji, et al.. (2004). Vascular endothelial growth factor and interleukin 6 expression by Hodgkin/Reed‐Sternberg cells. British Journal of Haematology. 125(1). 1–1. 8 indexed citations
19.
20.
Hara, Satoshi. (1976). Influence of defective circulation of the posterior ciliary arteries on acid hydrolases in the choroid and the retina. Japanese Journal of Ophthalmology. 20(3). 353–360. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jian Qi Breakdown of academic impact, for papers by Julia Glade Bender Breakdown of academic impact, for papers by Youngil Koh Breakdown of academic impact, for papers by Rong Hu Breakdown of academic impact, for papers by José Pinto Breakdown of academic impact, for papers by K.C. Balaji Breakdown of academic impact, for papers by Roel A. de Weger Breakdown of academic impact, for papers by Yimin Huang Breakdown of academic impact, for papers by Masayoshi Ishida
Rankless by CCL
2026